Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin
暂无分享,去创建一个
M. Levine | R. Black | J. Holmgren | A. Svennerholm | M. Clements | C. Young | R E Black | M M Levine | M L Clements | R. E. Black | J Holmgren | C R Young | A M Svennerholm
[1] D. Sack,et al. FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH , 1986, The Lancet.
[2] M. Levine,et al. Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology , 1985, Journal of clinical microbiology.
[3] D. Sack,et al. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. , 1984, The Journal of infectious diseases.
[4] M. Levine,et al. Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae , 1984, Infection and immunity.
[5] M. Levine,et al. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. , 1983, Microbiological reviews.
[6] J. Holmgren,et al. Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination) , 1983, Infection and immunity.
[7] W. Cray,et al. Oral Immunization of Dogs with Purified Cholera Toxin, Crude Cholera Toxin, or B Subunit: Evidence for Synergistic Protection by Antitoxic and Antibacterial Mechanisms , 1982, Infection and immunity.
[8] M. Levine,et al. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. , 1982, The Journal of infectious diseases.
[9] J. Holmgren. Actions of cholera toxin and the prevention and treatment of cholera , 1981, Nature.
[10] L. Cisneros,et al. Duration of infection-derived immunity to cholera. , 1981, The Journal of infectious diseases.
[11] M. Rennels,et al. Selective vs. nonselective media and direct plating vs. enrichment technique in isolation of Vibrio cholerae: recommendations for clinical laboratories. , 1980, The Journal of infectious diseases.
[12] M. Levine. Immunity to Cholera as Evaluated in Volunteers , 1980 .
[13] N. Pierce. The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats , 1978, The Journal of experimental medicine.
[14] J. Holmgren,et al. Development of improved cholera vaccine based on subunit toxoid , 1977, Nature.
[15] J. Holmgren,et al. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid , 1976, Infection and immunity.
[16] N. Pierce,et al. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. , 1974, The Journal of infectious diseases.
[17] J. Holmgren,et al. Enzyme-Linked Immunosorbent Assays for Cholera Serology , 1973, Infection and immunity.
[18] R. Finkelstein,et al. PATHOGENESIS OF EXPERIMENTAL CHOLERA : PREPARATION AND ISOLATION OF CHOLERAGEN AND CHOLERAGENOID , 1969 .
[19] J. Heremans,et al. Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.
[20] D. Sack,et al. Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. , 1984, Bulletin of the World Health Organization.
[21] J. Holmgren,et al. Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside. , 1981, European journal of biochemistry.
[22] A. Svennerholm. The Nature of Protective Immunity in Cholera1 , 1980 .
[23] K. Aziz,et al. Immunological aspects of a cholera toxoid field trial in Bangladesh. , 1978 .
[24] W. Dewitt,et al. A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75. , 1978, Bulletin of the World Health Organization.
[25] R. Wenzel,et al. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. , 1974, The Journal of infectious diseases.
[26] W. Mosley,et al. The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. , 1968, Bulletin of the World Health Organization.